| |
| |
|
| Insider
Information: |
Versant Venture Capital Vi, L.p. |
| Relationship: |
10% Owner |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
3,656,585 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
3,656,585 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Akero Therapeutics, Inc. |
AKRO |
10% Owner |
2019-12-31 |
3,656,585 |
2019-06-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-31 |
4 |
AS |
$23.48 |
$404,020 |
D/D |
(17,207) |
3,656,585 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-30 |
4 |
AS |
$24.39 |
$8,266,234 |
D/D |
(338,919) |
3,673,792 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-27 |
4 |
AS |
$22.58 |
$750,920 |
D/D |
(33,256) |
4,012,711 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-26 |
4 |
AS |
$22.48 |
$530,528 |
D/D |
(23,600) |
4,045,967 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-24 |
4 |
AS |
$21.70 |
$34,829 |
D/D |
(1,605) |
4,069,567 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-23 |
4 |
AS |
$21.56 |
$117,135 |
D/D |
(5,433) |
4,071,172 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-20 |
4 |
AS |
$19.80 |
$367,924 |
D/D |
(18,582) |
4,076,605 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-18 |
4 |
AS |
$19.50 |
$39,390 |
D/D |
(2,020) |
4,095,187 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-12-17 |
4 |
AS |
$19.58 |
$149,807 |
D/D |
(7,651) |
4,097,207 |
0 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
B |
$16.00 |
$6,400,000 |
D/D |
400,000 |
4,104,858 |
2.45 |
- |
|
| AKRO |
Akero Therapeutics, Inc. |
10% Owner |
– – • |
2019-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
3,704,858 |
3,704,858 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
